These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30821926)

  • 41. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB; Bae SC
    Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lupus low disease activity state as a treatment target for pediatric patients with lupus nephritis.
    Kisaoglu H; Baba O; Kalyoncu M
    Pediatr Nephrol; 2023 Apr; 38(4):1167-1175. PubMed ID: 36156735
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
    Wang M; Gladman DD; Ibañez D; Urowitz MB
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measuring Disease Activity and Damage with Validated Metrics: A Systematic Review on Mortality and Damage in Systemic Lupus Erythematosus.
    Keeling SO; Vandermeer B; Medina J; Chatterley T; Nevskaya T; Pope J; Alaburubalnabi Z; Bissonauth A; Touma Z
    J Rheumatol; 2018 Oct; 45(10):1448-1461. PubMed ID: 30111638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
    Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus.
    Elefante E; Tani C; Stagnaro C; Signorini V; Parma A; Carli L; Zucchi D; Ferro F; Mosca M
    Arthritis Res Ther; 2020 Oct; 22(1):241. PubMed ID: 33054823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis.
    Murimi-Worstell IB; Lin DH; Nab H; Kan HJ; Onasanya O; Tierce JC; Wang X; Desta B; Alexander GC; Hammond ER
    BMJ Open; 2020 May; 10(5):e031850. PubMed ID: 32444429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors and prognostic stratification for lupus low disease activity state: results from a prospective clinical trial.
    Zhang K; An Y; Zhao P; Huang B; Wang Y; Zhou X; Cheng G; Xing X; Wang N; Feng R; Yu S; Li M; He J; Li Z
    Rheumatology (Oxford); 2023 Mar; 62(3):1153-1161. PubMed ID: 35895025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB; Ibañez D; Jerome D; Gladman DD
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Caveats and pitfalls in defining low disease activity in systemic lupus erythematosus.
    Samões B; Zen M; Abelha-Aleixo J; Gatto M; Doria A
    Autoimmun Rev; 2022 Oct; 21(10):103165. PubMed ID: 35931316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How can we define low disease activity in systemic lupus erythematosus?
    Tselios K; Gladman DD; Urowitz MB
    Semin Arthritis Rheum; 2019 Jun; 48(6):1035-1040. PubMed ID: 30415943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of damage and mortality in SLE patients fulfilling the ACR or only the SLICC classification criteria. A 10-year, inception cohort study.
    Inês L; Rodrigues M; Jesus D; Fonseca FP; Silva JAP
    Lupus; 2018 Apr; 27(4):556-563. PubMed ID: 28933234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort.
    Reppe Moe SE; Molberg Ø; Strøm EH; Lerang K
    Lupus; 2019 Jun; 28(7):818-825. PubMed ID: 31072277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term mortality and morbidity of patients with systemic lupus erythematosus: a single-center cohort study in China.
    Wang Z; Li M; Wang Y; Xu D; Wang Q; Zhang S; Zhao J; Su J; Wu Q; Shi Q; Leng X; Zhang W; Tian X; Zhao Y; Zeng X
    Lupus; 2018 Apr; 27(5):864-869. PubMed ID: 29308727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Remission and low disease activity in systemic lupus erythematosus: an achievable goal even with fewer steroids? Real-life data from a monocentric cohort.
    Tani C; Vagelli R; Stagnaro C; Carli L; Mosca M
    Lupus Sci Med; 2018; 5(1):e000234. PubMed ID: 29531772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus.
    Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA
    J Rheumatol; 1997 Feb; 24(2):309-13. PubMed ID: 9034988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of damage accrual across different calendar periods in systemic lupus erythematosus patients.
    Pineau CA; Bernatsky S; Abrahamowicz M; Neville C; Karp I; Clarke AE
    Lupus; 2006; 15(9):590-4. PubMed ID: 17080914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
    Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
    Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort.
    Altabás-González I; Rúa-Figueroa I; Rubiño F; Mouriño Rodríguez C; Hernández-Rodríguez I; Menor Almagro R; Uriarte Isacelaya E; Tomero Muriel E; Salman-Monte TC; Carrión-Barberà I; Galindo M; Rodríguez Almaraz EM; Jiménez N; Inês L; Pego-Reigosa JM
    Rheumatology (Oxford); 2023 Mar; 62(3):1162-1169. PubMed ID: 35961050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.